GSD NovaPrime® SARS-CoV-2 (COVID-19) RT-PCR (2x384)

GSD NovaPrime® SARS-CoV-2 (COVID-19) RT-PCR (2x384)

GSD NovaPrime® Plus SARS-CoV-2 (1x96)

GSD NovaPrime® Plus SARS-CoV-2 (1x96)

GSD NovaType Select L452R SARS-CoV-2 (1x96)

The GSD NovaType Select L452R SARS-CoV-2 is a research use only (RUO) real-time reverse transcription PCR (RT-PCR) assay designed for the qualitative detection of the SARS-CoV-2 S gene mutation L452R.

The assay is designed to be used in combination with the GSD NovaType Select Base SARS-CoV-2 RT-PCR.

For Research Use Only.

Not available in the US.

Real-time RT-PCR assay designed for the qualitative detection of the SARS-CoV-2 S gene mutation L452R.

The assay is designed to be used in combination with the GSD NovaType Select Base SARS-CoV-2 RT-PCR.

Sample material should be genomic RNA extracted from human upper respiratory (nasal wash/swab, nasopharyngeal wash/swab, oropharyngeal swab) specimen types that have previously tested positive for SARS-CoV-2 RNA by diagnostic RT-PCR methods e.g. GSD NovaPrime® SARS-CoV-2 (COVID-19).

Further Select assays are available. The NovaType Select assay family detects the following mutations: K417N, K417T, L452R, T478K, E484K, P681R, P618H.

Key Features and benefits of the GSD NovaType Select family

  • • Customized assay set-up
  • • Confirmatory tests for detection of new emerging mutations
  • • Parallel discrimination of most relevant mutations in S gene
  • • Offered as combination of basis kit including the enzyme mastermix and a range of mutation specific sets including primer, probes and controls
  • • Specimen types: nasal lavage/smear, nasopharyngeal lavage/smear, oropharyngeal swab
  • • Validated PCR platforms: AriaDxTM and AriaMxTM (Agilent Technologies)
  • • RUO
More Information
SKU PCOVL452R3
No. of tests 96
Specificity Mutation L452R in SARS-CoV-2 variants
PCR cycler platforms AriaMxTM and AriaDxTM (Agilent Technologies)
Kit components Primer-Probe-Mix, Positive Control

Test Instructions